Adam Rosenberg is a Strategic Advisor and is currently a Venture Partner with RA Ventures, helping the firm launch and build innovative life sciences companies. Adam has 20+ years of industry experience and a strong track record as a CEO, director and advisor in healthcare and technology. This includes serving as CEO at Athenen Therapeutics, Link Medicine, Rodin Therapeutics, Sling Therapeutics and Teleos Therapeutics, and serving as a member of the board of directors for both public and private biotech companies.
